Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study

Journal of Pathology

Volumn 201, Issue 1, 2003, Pages 99-108

  Gazi, E ^a   Dwyer, J ^a   Gardner, P ^a   Ghanbari Siahkali, A ^a   Wade, A P ^a   Miyan, J ^a   Lockyer, N P ^a   Vickerman, J C ^a   Clarke, N W ^b   Shanks, J H ^c   Scott, L J ^b   Hart, C A ^b   Brown, M ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Benign prostate hyperplasia; Cell lines; FTIR microspectroscopy; Multivariate analysis; Prostate cancer

Indexed keywords

ACETONE; BARIUM DERIVATIVE; GLYCOGEN; PARAFFIN; PHOSPHATE;

ALGORITHM; ARTICLE; CANCER CELL CULTURE; CELL SUSPENSION; CHEMOMETRICS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFRARED SPECTROSCOPY; MALE; MALIGNANT TRANSFORMATION; METASTASIS; PILOT STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; STATISTICAL ANALYSIS; TISSUE PREPARATION; VIBRATION;

ADENOCARCINOMA; CELLS, CULTURED; DIAGNOSIS, DIFFERENTIAL; EPITHELIAL CELLS; HUMANS; MALE; MULTIVARIATE ANALYSIS; PILOT PROJECTS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TUMOR CELLS, CULTURED;

EID: 0141738579     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1421     Document Type: Article

References (27)

1. Cancer Stats, Mortality - UK. June 2002, Cancer Research UK. http://www.cancerresearchuk.org/images/11632/ cancerstats-mortality_2002.pdf [30 October 2002].
2. Seabury CA, Calenoff E, Ditlow C, et al. Evaluation of a new serum testing method for detection of prostate cancer. J Urol 2002; 168: 93-99.
3. Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. In Urological Pathology - The Prostate, Tannenbaum M (ed). Lee and Febiger: Philadelphia, 1977; 171-197.
4. Lattouf JB, Saad F. Gleason score on biopsy: is it reliable for predicting the final grade on pathology? BJU Int 2002; 90: 694-699.
5. Partin AW, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001; 58: 843-848.
6. Kattan MW. Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. J Clin Oncol 2002; 20: 3206-3212.
7. Narain V, Cher ML, Wood DP. Prostate cancer diagnosis, staging and survival. Cancer Metastasis Rev 2002; 21: 17-22.
8. Scott LJ, Clarke NW, George NJR, Shanks JH, Testa NG, Land SH. Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br J Cancer 2001; 84: 1417-1423.
9. Sinha AA, Quast, Barry J, et al. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma. Cancer 2002; 94: 3141-3149.
10. Benara DA. The future of cancer imaging. Metastasis Rev 2002; 21: 45-78.
11. Diem M, Boydston-White S, Chiriboga L. Infrared spectroscopy of cells and tissues: shining light onto a novel subject. Appl Spectrosc 1999; 53: 148A-161A.
12. Romeo M, Burden F, Quinn M, Wood B, McNaughton D. Infrared microspectroscopy and artificial neural networks in the diagnosis of cervical cancer. Cell Mol Biol 1998; 44: 179-187.
13. Lang SH, Clarke NW, George NJ, Allen TD, Testa NG. Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma. Prostate 1998; 34: 201-13.
14. Berthon P, Cussenot O, Hopwood L, Le Luc A, Maitland NJ. Functional expression of SV40 in normal human prostatic epithelial and fibroblastic cells: differentiation pattern of non-tumourigenic cell lines. Int J Oncol 1995; 6: 333-343.
15. Mickey DD, Stone KR, Wunderli H, Mickey GH, Paulson DF. Characterization of a human prostate adenocarcinoma cell line (DU-145) as a monolayer culture and as a solid tumor in athymic mice. Prog Clin Biol Res 1980; 37: 67-84.
16. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979; 17: 16-23.
17. Wang H-P, Wang H-C, Huang Y-J. Microscopic FTIR studies of lung cancer cells in pleural fluid. Sci Total Environ 1997; 204: 283-287.
18. Ramesh J, Salman A, Hammody Z, et al. Applications of FTIR microscopy for the characterization of malignancy: H-ras transfected murine fibroblasts as an example. J Biochem Biophys Methods 2001; 50: 33-42.
19. Stone N, Kendall C, Shepherd N, Crow P, Barr H. Near-infrared Raman spectroscopy for the classification of epithelial pre-cancers and cancers. J Raman Spectrosc 2002; 33: 564-573.
20. Bakker Schut TC, Wolthuis R, Caspers PJ, Puppels G. Real-time tissue characterization on the basis of in vivo Raman spectra. J Raman Spectrosc 2002; 33: 580-585.
21. Takahashi S, Satomi A, Yano K, et al. Estimations of glycogen levels in human colorectal cancer tissue: relationship with cell cycle and tumour outgrowth. J Gastroenterol 1999; 34: 474-480.
22. Swinnen JV, Verhoeven G. Androgens and the control of lipid metabolism in human prostate cancer cells. J Steroid Biochem Mol Biol 1998; 65: 191-198.
23. Costello LC, Franklin RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 1998; 35: 285-296.
24. Piris MA, Sanchez-Beato M, Villuendas R, Martinez JC. Oncogenes and tumour-suppressor genes. In Cell Proliferation in Cancer: Regulatory Mechanisms of Neoplastic Cell Growth, Lewis CE, Pusztai L, Yap E (eds). Oxford University Press: New York, 1996; 49.
25. Paluszkiewicz C, Kwiatek WM. Analysis of human cancer prostate tissues using FTIR microscopy and SRIXE techniques. J Mol Struct 2001; 565-566: 329-334.
26. Kukus-Kubala A, Braziewicz J, Banas D, Majewska U, Gozdz S, Urbaniak A. Trace element load in cancer and normal lung tissue. Nucl Instrum Methods Phys Res B 1999; 150: 193-199.
27. Huang Y-L, Sheu J-Y, Lin T-H. Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem 1999; 32: 131-136.